| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | SPDR SER TR | 750,000 | 49,718,000 | 8.06% | Put | |
| 2 | ISHARES TR | 100,000 | 28,946,000 | 4.69% | Put | |
| 3 | ISHARES TR | 225,000 | 27,947,000 | 4.53% | Put | |
| 4 | SAREPTA THERAPEUTICS INC | 400,000 | 24,564,000 | 3.98% | Put | |
| 5 | SAREPTA THERAPEUTICS INC | 350,000 | 21,494,000 | 3.49% | Call | |
| 6 | BIOGEN INC | 65,000 | 20,347,000 | 3.30% | Call | |
| 7 | CLOVIS ONCOLOGY INC | 500,000 | 18,025,000 | 2.92% | ||
| 8 | ZIMMER BIOMET HLDGS INC | 125,000 | 16,253,000 | 2.64% | ||
| 9 | ALEXION PHARMACEUTIC | 120,000 | 14,705,000 | 2.38% | ||
| 10 | NUVASIVE INC COM | 210,000 | 13,999,000 | 2.27% | ||
| 11 | GW PHARMACEUTICALS PLC | 100,000 | 13,273,000 | 2.15% | Call | |
| 12 | ABBOTT LABS | 300,000 | 12,687,000 | 2.06% | ||
| 13 | AERIE PHARMACEUTICALS INC | 300,000 | 11,322,000 | 1.84% | Call | |
| 14 | SPECTRANETICS CORP | 435,000 | 10,914,000 | 1.77% | ||
| 15 | BRISTOL MYERS SQUIBB CO | 200,000 | 10,784,000 | 1.75% | Call | |
| 16 | BOSTON SCIENTIFIC CORP | 450,000 | 10,710,000 | 1.74% | Call | |
| 17 | CELGENE CORP | 100,000 | 10,453,000 | 1.70% | ||
| 18 | Wright Medical Group NV | 425,000 | 10,425,000 | 1.69% | ||
| 19 | EDWARDS LIFESCIENCES CORP | 85,000 | 10,248,000 | 1.66% | ||
| 20 | PUMA BIOTECHNOLOGY | 150,000 | 10,058,000 | 1.63% | ||
| 21 | BOSTON SCIENTIFIC CORP | 400,000 | 9,520,000 | 1.54% | ||
| 22 | MERCK & CO INC | 150,000 | 9,362,000 | 1.52% | Call | |
| 23 | OPHTHOTECH CORP COM | 200,000 | 9,226,000 | 1.50% | Call | |
| 24 | SAREPTA THERAPEUTICS INC | 150,000 | 9,212,000 | 1.49% | ||
| 25 | DBV TECHNOLOGIES | 250,000 | 9,083,000 | 1.47% | ||
| 26 | SAGE THERAPEUTICS | 175,000 | 8,059,000 | 1.31% | ||
| 27 | BIOCRYST PHARMACEUTICALS | 1,800,000 | 7,938,000 | 1.29% | ||
| 28 | CELGENE CORP | 75,000 | 7,840,000 | 1.27% | Call | |
| 29 | Cynosure Inc | 150,000 | 7,641,000 | 1.24% | ||
| 30 | NANOSTRING TECHNOLOGIES INC | 375,000 | 7,493,000 | 1.22% | ||
| 31 | FLAMEL TECHNOLOGIES SA SPONSORED ADR | 575,000 | 7,130,000 | 1.16% | ||
| 32 | Lion Biotechnologies | 825,000 | 6,790,000 | 1.10% | ||
| 33 | PACIFIC BIOSCIENCES CALIF IN | 750,000 | 6,720,000 | 1.09% | ||
| 34 | ENANTA PHARMACEUTICALS INC COM | 250,000 | 6,653,000 | 1.08% | ||
| 35 | IMMUNOMEDICS INC | 2,000,000 | 6,500,000 | 1.05% | ||
| 36 | ACADIA PHARMACEUTICALS INC COM | 200,000 | 6,362,000 | 1.03% | ||
| 37 | NEVRO CORP | 60,000 | 6,263,000 | 1.02% | ||
| 38 | AXOVANT SCIENCES LTD | 400,000 | 5,600,000 | 0.91% | ||
| 39 | RETROPHIN INC COM | 250,000 | 5,595,000 | 0.91% | ||
| 40 | BIOMARIN | 60,000 | 5,551,000 | 0.90% | ||
| 41 | IONIS PHARMACEUTICALS INC | 150,000 | 5,496,000 | 0.89% | Call | |
| 42 | QIAGEN NV | 200,000 | 5,488,000 | 0.89% | ||
| 43 | HORIZON PHARMA PLC | 300,000 | 5,439,000 | 0.88% | Call | |
| 44 | ACORDA THERAPEUTICS | 250,000 | 5,220,000 | 0.85% | ||
| 45 | AERIE PHARMACEUTICALS INC | 125,000 | 4,718,000 | 0.77% | ||
| 46 | BIOGEN INC | 15,000 | 4,695,000 | 0.76% | ||
| 47 | ACLARIS THERAPEUTICS INC COM | 175,000 | 4,482,000 | 0.73% | ||
| 48 | ENTELLUS MEDICAL INC | 200,000 | 4,436,000 | 0.72% | ||
| 49 | PATHEON N V SHS | 275,700 | 4,298,000 | 0.70% | ||
| 50 | HORIZON PHARMA PLC | 225,000 | 4,079,000 | 0.66% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001387131-16-007894, filed 2016.11.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
